Related references
Note: Only part of the references are listed.Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Kwangsik Nho et al.
ALZHEIMERS & DEMENTIA (2019)
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome
Siamak MahmoudianDehkordi et al.
ALZHEIMERS & DEMENTIA (2019)
Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease
Josef Marksteiner et al.
METABOLOMICS (2018)
HMDB 4.0: the human metabolome database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Religious Orders Study and Rush Memory and Aging Project
David A. Bennett et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
GSimp: A Gibbs sampler based left-censored missing value imputation approach for metabolomics studies
Runmin Wei et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma et al.
PLOS MEDICINE (2018)
Application of Metabolomics in Alzheimer's Disease
Jordan Maximillian Wilkins et al.
FRONTIERS IN NEUROLOGY (2018)
Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data
Runmin Wei et al.
SCIENTIFIC REPORTS (2018)
Early identification of MCI converting to AD: a FDG PET study
Marco Pagani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study
Stuart G. Snowden et al.
PLOS MEDICINE (2017)
Metabolic network failures in Alzheimer's disease: A biochemical road map
Jon B. Toledo et al.
ALZHEIMERS & DEMENTIA (2017)
Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease
Xiaobei Pan et al.
METABOLITES (2017)
Blood-brain barrier damage in vascular dementia
Masaki Ueno et al.
NEUROPATHOLOGY (2016)
Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
Raul Gonzalez-Dominguez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Profiling of Serum Bile Acids in a Healthy Chinese Population Using UPLC-MS/MS
Guoxiang Xie et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Fruit flies, bile acids, and Parkinson disease A mitochondrial connection?
J. Timothy Greenamyre et al.
NEUROLOGY (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms
Matthew Quinn et al.
DIGESTIVE AND LIVER DISEASE (2014)
Human Cerebrospinal Fluid Fatty Acid Levels Differ between Supernatant Fluid and Brain-Derived Nanoparticle Fractions, and Are Altered in Alzheimer's Disease
Alfred N. Fonteh et al.
PLOS ONE (2014)
Overview and Findings from the Rush Memory and Aging Project
David A. Bennett et al.
Current Alzheimer Research (2013)
Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease
Anniina Snellman et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Potential metabolite markers of schizophrenia
J. Yang et al.
MOLECULAR PSYCHIATRY (2013)
Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer's Disease Using Metabolomics
Eugenia Trushina et al.
PLOS ONE (2013)
Pathway-based personalized analysis of cancer
Yotam Drier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
Mladena Lalic-Popovic et al.
JOURNAL OF DIABETES RESEARCH (2013)
Relation of neuropathology to cognition in persons without cognitive impairment
David A. Bennett et al.
ANNALS OF NEUROLOGY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABAA receptors
S. R. Schubring et al.
NEUROSCIENCE LETTERS (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells
Ryan W. Mitchell et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Linking lipids to Alzheimer's disease: cholesterol and beyond
Gilbert Di Paolo et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Microinfarct Pathology, Dementia, and Cognitive Systems
Zoe Arvanitakis et al.
STROKE (2011)
Metabolome in progression to Alzheimer's disease
M. Oresic et al.
TRANSLATIONAL PSYCHIATRY (2011)
The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment
Julie A. Schneider et al.
ANNALS OF NEUROLOGY (2009)
A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
Nicola Greenberg et al.
ELECTROPHORESIS (2009)
Serum Metabolite Profiling of Human Colorectal Cancer Using GC-TOFMS and UPLC-QTOFMS
Yunping Qiu et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Inflammaging as a prodrome to Alzheimer's disease
Brian Giunta et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Rene O. Sanchez-Mejia et al.
NATURE NEUROSCIENCE (2008)
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
Rita M. Ramalho et al.
TRENDS IN MOLECULAR MEDICINE (2008)
The epidemiology of the dementias: an update
Chengxuan Qiu et al.
CURRENT OPINION IN PSYCHIATRY (2007)
Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid β-peptide-induced apoptosis
Susana Sola et al.
MOLECULAR ENDOCRINOLOGY (2006)
Neuropathology of older persons without cognitive impairment from two community-based studies
D. A. Bennett et al.
NEUROLOGY (2006)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study
David A. Bennett et al.
NEUROEPIDEMIOLOGY (2006)
Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons
S Patil et al.
NEUROSCIENCE LETTERS (2005)
A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid
KJ Moore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Natural history of mild cognitive impairment in older persons
DA Bennett et al.
NEUROLOGY (2002)
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils
IS Coraci et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Essential fatty acids and the brain: possible health implications
KA Youdim et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)